Ontology highlight
ABSTRACT: Introduction
While intravenous human immunoglobulin therapy is potentially lifesaving for rare diseases, the significant costs associated with its usage warrant due attention. This study evaluated the costs and prescribing patterns of IVIg.Methods
This was a retrospective analysis of medical records in a tertiary hospital. The evidence category IIA and below, as well as strength of recommendations level B and below were classified as lower evidence category and lower strength of recommendation, respectively. Patients' demographic data, indications, dosing regimen, physician specialty were retrieved from medical records, while the cost was derived based on total prescribed doses.Results
Out of 78 patients, more than half of the patients were prescribed with off-label
SUBMITTER: Choo SJ
PROVIDER: S-EPMC9040375 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature